Your browser doesn't support javascript.
loading
Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.
Dubé, Karine; Eskaf, Shadi; Barr, Liz; Palm, David; Hogg, Evelyn; Simoni, Jane M; Sugarman, Jeremy; Brown, Brandon; Sauceda, John A; Henley, Laney; Deeks, Steven; Fox, Lawrence; Gandhi, Rajesh T; Smith, Davey; Li, Jonathan Z.
Afiliação
  • Dubé K; Public Health Leadership Program and Health Policy and Management, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
  • Eskaf S; UNC School of Government, Chapel Hill, North Carolina, USA.
  • Barr L; Community Scientific Sub-Committee, AIDS Clinical Trials Group (ACTG), Baltimore, Maryland, USA.
  • Palm D; Community Scientific Sub-Committee, AIDS Clinical Trials Group (ACTG), Baltimore, Maryland, USA.
  • Hogg E; Institute of Global Health and Infectious Diseases (IGHID), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Simoni JM; Social and Scientific Systems, Inc., a DLH Holdings Company, Silver Spring, Maryland, USA.
  • Sugarman J; Department of Psychology, University of Washington, Seattle, Washington, USA.
  • Brown B; Department of Global Health, and Women, and Sexuality Studies, University of Washington, Seattle, Washington, USA.
  • Sauceda JA; Department of Gender, Women, and Sexuality Studies, University of Washington, Seattle, Washington, USA.
  • Henley L; Johns Hopkins Berman Institute for Bioethics, Baltimore, Maryland, USA.
  • Deeks S; Center for Healthy Communities, Department of Social Medicine, Population and Public Health, University of California, Riverside School of Medicine, Riverside, California, USA.
  • Fox L; Center for AIDS Prevention Studies (CAPS), Division of Prevention Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Gandhi RT; Public Health Leadership Program and Health Policy and Management, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
  • Smith D; Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, California, USA.
  • Li JZ; Division of AIDS (DAIDS), National Institute of Health (NIH), Bethesda, Maryland, USA.
AIDS Res Hum Retroviruses ; 38(6): 510-517, 2022 06.
Article em En | MEDLINE | ID: mdl-35323030

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Síndrome da Imunodeficiência Adquirida Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Síndrome da Imunodeficiência Adquirida Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article